| Name | Title | Contact Details |
|---|---|---|
Thomas Schoeing |
Chief Information Officer | Profile |
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Proudly celebrating its 75th anniversary in 2013, Independence Blue Cross is the leading health insurer in southeastern Pennsylvania. With our affiliates, we have 3.1 million members nationwide. We are enhancing the health and wellness of the people and communities we serve by delivering innovative and competitively priced health care products and services; pioneering new ways to reward doctors, hospitals, and other health care professionals for coordinated, quality care; and supporting programs and events that promote wellness.
Anhydro A/S is a Elkridge, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SummitHMR is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bio Compression Systems Inc is a Moonachie, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.